Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurotransmitter Agents”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Early research (Phase 1)Study completedNCT04032301
What this trial is testing

Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans

Who this might be right for
Post-Traumatic Stress DisordersMajor Depressive Disorder
University of Minnesota 67
Not applicableUnknownNCT06204965
What this trial is testing

The Impact of Time-restricted Eating on the Outcomes Associated With Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary Syndrome
Joanna Bajerska 52
Large-scale testing (Phase 3)Looking for participantsNCT06752759
What this trial is testing

Nebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting

Who this might be right for
Severe DepressionModerate DepressionKetamine+16 more
Theresa Jacob, PhD, MPH 40
Early research (Phase 1)Study completedNCT02577250
What this trial is testing

Ketamine Infusions for PTSD and Treatment-Resistant Depression

Who this might be right for
Depressive Disorder, Treatment-ResistantStress Disorders, Post-Traumatic
Minneapolis Veterans Affairs Medical Center 20
Post-approval studies (Phase 4)Study completedNCT05615948
What this trial is testing

Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression

Who this might be right for
Treatment Resistant DepressionMajor Depressive DisorderAnalgesia+10 more
Maimonides Medical Center 15
Early research (Phase 1)UnknownNCT05143424
What this trial is testing

Evaluation of the Interactions of Cannabidiol (CBD) With Morphine

Who this might be right for
Opioid Use Disorder
National Institute on Drug Abuse (NIDA) 60
Large-scale testing (Phase 3)Study completedNCT01916967
What this trial is testing

An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201)

Who this might be right for
Urticaria
Organon and Co 239
Not applicableNot Yet RecruitingNCT07079046
What this trial is testing

Efficacy of Satisens® in Reducing Emotional Eating

Who this might be right for
Emotional EatingOverweight or ObesityHormonal Changes+5 more
José Enrique de la Rubia Ortí, Ph 84
Testing effectiveness (Phase 2)Ended earlyNCT02227368
What this trial is testing

Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR

Who this might be right for
Peripheral Artery Disease (PAD)
AstraZeneca 40
Very early researchActive Not RecruitingNCT05953038
What this trial is testing

LSD Occupancy of the Serotonin 2A Receptor in the Human Brain

Who this might be right for
Basic Science
Rigshospitalet, Denmark 40
Not applicableUnknownNCT04622904
What this trial is testing

Lidocaine and Magnesium and Ketamine in Gynecological Surgery

Who this might be right for
Pain, PostoperativePain, AcutePain, Chronic+8 more
Aretaieion University Hospital 90
Not applicableStudy completedNCT01366196
What this trial is testing

Pregabalin for the Treatment of Pain After Posterior Spinal Fusions

Who this might be right for
Lumbar Spinal Fusions
Hospital for Special Surgery, New York 86
Early research (Phase 1)Study completedNCT04178993
What this trial is testing

Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]

Who this might be right for
Methamphetamine Use Disorder
Craig Rush 8
Post-approval studies (Phase 4)UnknownNCT01710163
What this trial is testing

Potentiation of Quetiapine Treatment With Lithium or Aripiprazole in Bipolar 1 Nonresponders Patients

Who this might be right for
Bipolar I Disorder
University of Sao Paulo 50
Testing effectiveness (Phase 2)UnknownNCT04228653
What this trial is testing

Long-Term Follow-up Safety After DDS Implantation With/Without CDNF Infusions

Who this might be right for
Parkinson DiseaseMovement DisordersNeuro-Degenerative Disease+2 more
Renishaw 15
Not applicableLooking for participantsNCT06462196
What this trial is testing

Natural History of Depression, Bipolar Disorder and Suicide Risk

Who this might be right for
Behavioral SymptomsSuicideSelf-Injurious Behavior+18 more
National Institute of Mental Health (NIMH) 500
Testing effectiveness (Phase 2)Study completedNCT02634684
What this trial is testing

Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.

Who this might be right for
Schizophrenia
University of California, San Diego 82
Early research (Phase 1)Study completedNCT03733574
What this trial is testing

LY03005 vs Pristiq

Who this might be right for
Major Depressive Disorder
Luye Pharma Group Ltd. 56
Post-approval studies (Phase 4)Study completedNCT02695992
What this trial is testing

Rate Control in Atrial Fibrillation II

Who this might be right for
Atrial FibrillationPermanent Atrial Fibrillation
Asker & Baerum Hospital 122
Early research (Phase 1)Study completedNCT03822065
What this trial is testing

A Relative Bioavailability Food Effect Study of LY03005

Who this might be right for
Major Depressive Disorder
Luye Pharma Group Ltd. 34
Load More Results